DI
HRTX icon

DDFG Inc’s Heron Therapeutics HRTX Stock Holding History

DDFG Inc’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Buy
+32,903
New +$26.4K ﹤0.01% 92

Other funds holding HRTX

CPC
Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
AR
Apeiron RIA Dallas, Texas $390M AUM 22.97% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
SC
Searle & Co Greenwich, Connecticut $445M AUM 41.72% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

DDFG Inc's HRTX Position: Q2 2026 in Review

DDFG Inc opened a new position in Heron Therapeutics (HRTX) in Q2 2026: 32,903 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #92 among its holdings.

38 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • DDFG Inc held 32,903 shares of Heron Therapeutics worth $14K as of Q2 2026.
  • Heron Therapeutics was a new DDFG Inc position in Q2 2026.
  • Heron Therapeutics made up ﹤0.01% of DDFG Inc's portfolio in Q2 2026, its #92 holding.
  • 38 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on DDFG Inc's 13F filing for Q2 2026, filed 28 Jul 2026.